oncologypro
Published 1 year ago • 258 plays • Length 1:54Download video MP4
Download video MP3
Similar videos
-
1:31
esmo oncologypro - intro by prof. a. matikas
-
1:53
esmo oncologypro - presentation by dr. e. smyth
-
1:46
esmo oncologypro - intro by dr. e. smyth
-
9:07
european society for medical oncology (esmo) 2023 - abstracts #2362mo and #2359o
-
7:28
expert report on panitumumab for first line treatment of ras wild type mcrc from asco 2022
-
2:25
oncologypro, a 360 research solution designed around you
-
0:58
esmo translational unit visit
-
8:55
how to manage chemotherapy induced nausea and vomiting
-
9:57
how to select 1st line therapy for metastatic renal cell cancer?
-
8:15
why choose medical oncology? expert perspective
-
8:34
#esmo21 expert video report on melanoma
-
4:59
desmoid fibromatosis, when and how to treat?
-
1:21
esmo essentials for clinicians: gastrointestinal tract tumours - 2nd edition
-
3:25
highlights on lu-psma-617 in taxane-naive patients with mcrpc: the psmafore study
-
4:05
how to assess and manage cancer pain?
-
5:18
expert video report on amivantamab in combination therapy for 1l treatment in egfrm, advanced nsclc
-
4:50
expert report on tackling resistance to cdk4/6 inhibitors in er /her2-metastatic breast cancer
-
5:30
expert report on immune checkpoint inhibitors for dmmr colorectal cancer
-
7:00
expert report on neoadjuvant immune checkpoint inhibitors for nsclc
-
9:55
asco 2023 expert report on novelties in the treatment of colorectal cancer by s. stintzing
-
3:21
esmo 2020 highlights on pembrolizumab as 1st line therapy for auc: the keynote-361 study